A team of researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has developed a ...

Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...

Researchers at the University of California, San Francisco have uncovered a mechanism that could transform the fight against ...